189 related articles for article (PubMed ID: 30552913)
21. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
22. Anti-Trichomonas vaginalis activity of chalcone and amino-analogues.
Trein MR; Rodrigues E Oliveira L; Rigo GV; Garcia MAR; Petro-Silveira B; da Silva Trentin D; Macedo AJ; Regasini LO; Tasca T
Parasitol Res; 2019 Feb; 118(2):607-615. PubMed ID: 30535524
[TBL] [Abstract][Full Text] [Related]
23. Anti-Trichomonas vaginalis activity and chemical analysis of metabolites produced by marine-associated fungi.
Senger FR; Campos-Silva R; Landell MF; Silva DB; Menezes CB; Rigo GV; Silva LN; Trentin DS; Macedo AJ; Tasca T
Parasitol Res; 2022 Mar; 121(3):981-989. PubMed ID: 35113221
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of urogenital trichomoniasis of both sexes with tinidazol (Fasygin)].
Rainer A
Wien Med Wochenschr; 1974 Oct; 124(42-43):625-6. PubMed ID: 4548265
[No Abstract] [Full Text] [Related]
25. Transmission electron microscopy revealing the mechanism of action of photodynamic therapy on Trichomonas vaginalis.
Fonseca THS; Gomes JMS; Alacoque M; Vannier-Santos MA; Gomes MA; Busatti HGNO
Acta Trop; 2019 Feb; 190():112-118. PubMed ID: 30447179
[TBL] [Abstract][Full Text] [Related]
26. Chlorinated metronidazole as a promising alternative for treating trichomoniasis.
Chacon MO; Fonseca THS; Oliveira SBV; Alacoque MA; Franco LL; Tagliati CA; Cassali GD; Campos-Mota GP; Alves RJ; Capettini LSA; Gomes MA
Parasitol Res; 2018 May; 117(5):1333-1340. PubMed ID: 29502297
[TBL] [Abstract][Full Text] [Related]
27. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
[TBL] [Abstract][Full Text] [Related]
28. The clinical spectrum of Trichomonas vaginalis infection and challenges to management.
Muzny CA; Schwebke JR
Sex Transm Infect; 2013 Sep; 89(6):423-5. PubMed ID: 23543252
[TBL] [Abstract][Full Text] [Related]
29. Recalcitrant Trichomonas vaginalis infections successfully treated with vaginal acidification.
Aggarwal A; Shier RM
J Obstet Gynaecol Can; 2008 Jan; 30(1):55-58. PubMed ID: 18198069
[TBL] [Abstract][Full Text] [Related]
30. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
31. Gold(I) Phosphine Derivatives with Improved Selectivity as Topically Active Drug Leads to Overcome 5-Nitroheterocyclic Drug Resistance in
Miyamoto Y; Aggarwal S; Celaje JJA; Ihara S; Ang J; Eremin DB; Land KM; Wrischnik LA; Zhang L; Fokin VV; Eckmann L
J Med Chem; 2021 May; 64(10):6608-6620. PubMed ID: 33974434
[No Abstract] [Full Text] [Related]
32. Prolonged vaginal and oral metronidazole for refractory Trichomonas vaginalis: a case report.
Wood S; Kennedy CM; Galask RP
J Reprod Med; 2007 Nov; 52(11):1057-8. PubMed ID: 18161407
[TBL] [Abstract][Full Text] [Related]
33. Trichomonas vaginalis: treatment questions and challenges.
Secor WE
Expert Rev Anti Infect Ther; 2012 Feb; 10(2):107-9. PubMed ID: 22339182
[No Abstract] [Full Text] [Related]
34. Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries.
Huang HN; Rajanbabu V; Pan CY; Chan YL; Wu CJ; Chen JY
Biomaterials; 2013 Dec; 34(38):10319-27. PubMed ID: 24075409
[TBL] [Abstract][Full Text] [Related]
35.
Ghosh AP; Aycock C; Schwebke JR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
[TBL] [Abstract][Full Text] [Related]
37. Recombinant α-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis.
Xie YT; Gao JM; Wu YP; Tang P; Hide G; Lai DH; Lun ZR
Parasit Vectors; 2017 Feb; 10(1):83. PubMed ID: 28209207
[TBL] [Abstract][Full Text] [Related]
38. [Effect of sodium nitrite on Trichomonas vaginalis].
Ryu JS; Park JW; Min DY
Korean J Parasitol; 1995 Dec; 33(4):349-56. PubMed ID: 8591013
[TBL] [Abstract][Full Text] [Related]
39. Antiparasitic activity of 1,3-dioxolanes containing tellurium in Trichomonas vaginalis.
Sena-Lopes Â; das Neves RN; Bezerra FSB; de Oliveira Silva MT; Nobre PC; Perin G; Alves D; Savegnago L; Begnini KR; Seixas FK; Collares T; Borsuk S
Biomed Pharmacother; 2017 May; 89():284-287. PubMed ID: 28236702
[TBL] [Abstract][Full Text] [Related]
40. Trichomonas vaginalis NTPDase inhibited by lycorine modulates the parasite-neutrophil interaction.
Petró-Silveira B; Rigo GV; da Silva Trentin D; Macedo AJ; Sauer E; de Oliveira Alves E; Tallini LR; Garcia SC; de Souza Borges W; Zuanazzi JÂS; Tasca T
Parasitol Res; 2020 Aug; 119(8):2587-2595. PubMed ID: 32524267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
